It is therefore essential that misdiagnosis and unnecessary procedures are reduced by the development of non-invasive approaches such as blood tests/liquid biopsies that are more accurate at detecting and categorizing the clinical risk of PCa than the PSA test. Here, KLK3 is linked to posterior cortical atrophy.